EPP Life Sciences Executive Round Table | Zurich, Switzerland.

Another successful EPP event in collaboration with

Alliance Life Sciences.

We were pleased to welcome at the tables some passionate pricing and market access leaders from the Pharma and MedTech industry:

Amgen /Becton Dickinson/ALK Abelló/ Sonova AG/Edwards Lifesciences/ Biogen/ Roche Diagnostics/ Ferring International Center S.A/Novartis Oncology/Teva Olympus Europa SE & CO. KG/ Baxter Healthcare SA/…

Some  testimonials…

“The topics were focused and relevant.”       “Good, the meeting was very valuable and fully met my expectations.”

“It was great to have small focused groups with others that are experts in the field.”

“Very interesting attendees with diverse companies and backgrounds at the table; good introductory presentations, interesting topics that were discussed in groups

“All presentations were interesting and well prepared.”

 “I liked the focus. I do not think we could do more within the timeframe.”

Key themes discussed on the tables

  • The European MedTech pricing environment is likely to become increasingly challenging:
    • Healthcare spending  in the EU28 overall has increased only with GDP for the last 5 years
    • What increases have occurred have come from direct patient payments
    • An increasingly aging population will drive increasing focus on cost-reduction
  • Pricing in the MedTech industry will need to take a value-based and pragmatic approach
    • Understand the source of value (cost reduction, patient benefit, other) and implications for pricing
    • Design a ‘price architecture’ that captures a fair share of value delivered
    • Assess the impact of innovation on multiple healthcare stakeholders (patients, providers,
      payers and society)
  • New technologies will create both opportunities and challenges: increased the need for well-designed pricing architectures, effective price decision-making and price monitoring.

Main objectives?

  • Bringing together 30 pricing and market access leaders from the Pharma and MedTech industry. Together we want to initiate a thought leadership dialogue on emerging pricing and commercial topics in the global Life Sciences market.
  • At the end of the day we’re able to determine together a number of trends, which are essential for tackling the current pricing challenges and solutions in the global Life Sciences Market in 2017 and beyond.
  • These prominent developments are laying the foundation for the agenda of the upcoming 7th EPP Life Sciences Forum to be organised again in the wonderful city of Montreux. For more information on the upcoming EPP Life Sciences Forum, click here

From Els, the conference manager :

A big thank you to all attendees who made this event a success!

Join our next great Life Sciences Pricing Event in Montreux!

Find out more here or  send an email to els.anduyt@pricingplatform.eu for more information & ticket bookings.

Els Landuyt – Life Sciences Manager


 

Become a participant in the European Pricing Platform community!

  • 1 BUILD RELATIONSHIPS

    With more than 1000 minutes of network opportunity, you have plenty of time to connect with pricing colleagues from all over Europe.

  • 2 DISCUSS

    We stimulate an atmosphere of discussion and interaction, the best way to learn.

  • 3 LEARN FROM THE BEST

    A carefully selected speaking team of top pricing professionals, all active within your industry. No general talk, but only to-the point and useful presentations.

  • 4 REFLECT & PRACTICE

    Reflect on your key priorities and how to make it really happen !  Translate your key learnings into real change.

SPEAKERS AND FACILITATORS

EPP - together with its Founding Partner Alliance Life Sciences - focus on bringing together an exclusive group of pricing related professionals of the Life Sciences industries to create a one-of-a-kind learning and networking experience. To be able to achieve this, EPP invites only top level speakers, who are each of them experts in their domains. Judge for yourself!

Alan Crowther – President Global Markets (USA)

President, Global Markets - Alliance Life Sciences Alliance Life Sciences


Alan Crowther, CEO for Alliance Life Sciences, is an industry recognized authority on global pricing and revenue management. With 20 years of consulting and technology experience in the Life Sciences industry, Alan’s leadership is focused on continually innovating to solve business challenges.

 

ASK A QUESTION

Ian Tidswell – Independent Consultant (Switzerland)

Independent Consultant Een Consulting


Founder and lead consultant for EEN Consulting since 2016.  Focus on helping B2B companies develop best-in-class end-to-end sustainable Independent consultant focusing on helping B2B companies develop best-in-class end-to-end sustainable processes. Over 15 years of experience in pricing, with several companies such as GE, Syngenta, Medtronic and Vendavo, with deep experience in pricing strategy, price setting, commercial terms design and price execution (including pricing decision support systems).

ASK A QUESTION

Dr. Carolin Miltenburger PhD – Payer Strategy Consultant Life Sciences (Germany)

Payer Strategy Consultant Life Sciences Carolin Miltenburger


Carolin is a strategy consultant focused on market access for medical devices and pharmaceuticals. She helps companies to develop and implement strategies and organizational solutions to define and show the value of healthcare technologies (diagnostics, drugs, devices) to payers, healthcare providers and patients. Support of full product life cycle from proof of concept (POC) to patent loss (LOE). Psychologist (PhD), health economist and organizational consultant with 25+ years experience in international consultancy and global leadership positions.

ASK A QUESTION

OUR STEERING COMMITTEE FOR THE LIFE SCIENCES INDUSTRY

Sara Aswegan (Switzerland)

Senior Vice President Ultragenyx Pharmaceuticals Inc.


About Sara

Sara has recently joined Ultragenyx Pharmacuetical Inc. as Senior Vice-President. Before that she led the Product Strategy Teams for the MPS II Business in the Rare Disease Business Unit, supporting the second largest revenue contributor for Shire with ELAPRASE, as well as plans for commercial success with the development products for Hunter CNS.

Bertrand Tardivel (Switzerland)

Head of Global Pricing Takeda Pharmaceuticals International


About Bertrand

Bertrand joined Takeda in August 2013 as Head of Global Pricing. Moving from controller to consultant and business development manager for different companies, he has built a broad experience in the pharmaceutical sector. With Takeda he joined a company that for more than 230 years has been serving society with innovative medicines, helping patients reclaim valuable moments of life from illness.

Adam Plich (The Netherlands)

VP, Head of Pricing & Market Access Europe TEVA Pharmaceutical Europe


About Adam

Adam has been working with Teva since 2012 as Head of Pricing and Market Access, first based in London now in Amsterdam.  Teva Pharmaceutical is the world’s largest generic medicines producer, leveraging its portfolio of more than 1,000 molecules to produce a wide range of generic products in nearly every therapeutic area. In specialty medicines, Teva has a world-leading position in innovative treatments for disorders of the central nervous system, including pain, as well as a strong portfolio of respiratory products.

Photo Daniel Cho

Daniel Cho (Germany)

Director Marketing, Global Pricing & Competitive Portfolio Analytics - Patient Care and Monitoring Solutions Philips Healthcare


About Daniel

Daniel Cho is currently the Director of Global Pricing for Patient Care and Monitoring Systems, a 3B Euro Business Group under Philips Healthcare. He heads a team of Pricing Managers to use Pricing as a tool to maximise the profitability of PCMS by better manage the Creation, Capturing and Maintenance of the values PCMS can deliver to their end customers.

Finn Ziegler (Denmark)

Director, Global Patient Access LEO Pharma


About Finn

Finn has recently joined LEO Pharma, after having worked for 6 years as International Contracts and Pricing Manager with Amgen, responsable for pricing and contract strategy and implementation.

His specialties lie in the domain of pricing research & strategies, health economics, public procurement and reimbursement of pharmaceuticals, public policy & affairs, think tanks, parallel trade and reference pricing in the pharmaceutical industry

Alan Crowther – President Global Markets (USA)

President, Global Markets - Alliance Life Sciences Alliance Life Sciences


Alan Crowther, CEO for Alliance Life Sciences, is an industry recognized authority on global pricing and revenue management. With 20 years of consulting and technology experience in the Life Sciences industry, Alan’s leadership is focused on continually innovating to solve business challenges.

 

WHAT ATTENDEES LIKED ABOUT LAST YEAR'S EVENT

Amgen

Oliver van Zon, International Pricing Director at Amgen

Strong interactive format with participants driving the break-out topics!

“This is a really good environment to be in.”

Klaas Postema, Executive Director Market Access at Actavis

I’m open to the discussion to sharpen the mind. This is a really good environment to be in.

“It’s much more lively and interactive!”

Madalina Preda, European Pricing Supervisor at Corning BV

It is much more lively and focussed on burning issues in the Life Science markets.

Meet pricing decision makers from:

VENUE

The Renaissance Zurich Tower Hotel is located in the vibrant Zurich West quarter, 5 minutes from downtown Zurich and 15 minutes from Zurich Airport. Enjoy the expertise and business services only Renaissance can offer.

Turbinenstrasse 20 – 8005 Zurich – Switzerland

t: +41 44 630 3030 f: +41 44 630 33 33

renaissancezurichtower.com

CONTENT

First name*

Last name*

Company*

Function

Sector

Country

Email*

I got a question for

My question

EPP PARTNERSHIPS

This unique event is organised by the European Pricing Platform together with its Founding Partner Alliance Life Sciences.

Registration for the EPP Executive Round Table